Darren Hodgson

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · The Lancet Oncology · 2014 · 1.4K citations

Olaparib Maintenance Therapy, Serous Ovarian Cancer, Medicine +8

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial

Jonathan A. Ledermann, Philipp Harter, Charlie Gourley et al. · The Lancet Oncology · 2016 · 444 citations · Full text

Overall Survival, Medicine, Metronomic Therapy +10

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

Noel W. Clarke, Paweł Wiechno, B. Yа. Alekseev et al. · The Lancet Oncology · 2018 · 405 citations · Full text

Urology, Oncology, Genitourinary Cancer +5

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Christopher Abbosh, Alexander M. Frankell, Thomas Harrison et al. · Nature · 2023 · 304 citations · Full text

Engineering, Oncologic Imaging, Cancer Detection +8

Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer

Yung‐Jue Bang, Seock‐Ah Im, Keun‐Wook Lee et al. · Journal of Clinical Oncology · 2015 · 289 citations · Full text